Carmen Navarro
Carmen Navarro has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Teppa Garrán
Sociedad de Obstetricia y Ginecología de Venezuela. Sección de Medicina Reproductiva. Policlínica Metropolitana, Caracas. Fertigenetics, Santa Paula
1 shared publication - Alejandro Teppa-Garrán
Departamento de Andrología, Clínica El Avila, Caracas, Venezuela
1 shared publication - Cesare Aragona
Systems Biology Group Lab, 00161 Rome, Italy
1 shared publication - Maria Salomé Bezerra Espinola
The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00156 Rome, Italy
1 shared publication - Panayiotis M. Zavos
University of Kentucky, Lexington, KY 40504, USA
1 shared publication Pedro Torrecillas Cabrera
Medical Center of Urology, Andrology and Sexual Medicine of Malaga, Spain
1 shared publication
Latest Publications
- 27 August 2026
- Published by Sociedad de Obstetricia y Ginecologia de Venezuela in Revista de Obstetricia y Ginecología de Venezuela
- Vol. 86 (Sup 1) , 42-49
Actualización sobre el manejo de pacientes con síndrome ovárico metabólico poliendocrino e infertilidad
- 27 August 2026
- Published by Sociedad de Obstetricia y Ginecologia de Venezuela in Revista de Obstetricia y Ginecología de Venezuela
- Vol. 86 (Sup 1) , 42-49
Actualización sobre el manejo de pacientes con síndrome ovárico metabólico poliendocrino e infertilidad
- Open Access
- 29 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 875
Use of Autologous Exosomes to Enhance Oocyte Maturation in Patients with Diminished Ovarian Reserve: A Prospective, Randomized Clinical Trial (Pilot Study)
Oocyte development begins during embryonic life and remains arrested in prophase I until meiotic resumption during ovulation. A substantial proportion of oocytes retrieved during assisted reproductive procedures remain immature at the metaphase I (MI) stage and fail to achieve the maturation required for fertilization. In women with diminished ovarian reserve, alterations in the ovarian microenvironment may impair the biochemical signaling necessary for normal oocyte development. Autologous exosomes have emerged as a potential strategy to enhance meiotic progression through the transfer of bioactive molecules. This study aimed to evaluate the in vitro efficacy of autologous exosomes in improving the maturation potential of immature oocytes in women with diminished ovarian reserve. A prospective, randomized, controlled pilot study was conducted in 32 women aged 38–46 years. A total of 111 oocytes were retrieved (52 metaphase II [MII] and 59 MI oocytes), and only MI oocytes were included in the experimental analysis. MI oocytes were cultured either in conventional medium or in medium supplemented with autologous exosomes. The exosome-supplemented group demonstrated significantly higher in vitro maturation rates compared with the conventional culture group (63.63% vs. 11.53%; p < 0.001). Fertilization rates among matured oocytes were 76.19% and 33.33% in Groups II and I, respectively. In addition, favorable embryo development outcomes were observed in the exosome-treated group. Autologous exosome supplementation may enhance in vitro maturation and fertilization outcomes in women with diminished ovarian reserve. After accounting for clustering of oocytes within patients using generalized estimating equations, exosome supplementation remained significantly associated with successful oocyte maturation (OR 15.46, 95% CI 5.16–46.39; p < 0.001).
- 29 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 875
Open AccessUse of Autologous Exosomes to Enhance Oocyte Maturation in Patients with Diminished Ovarian Reserve: A Prospective, Randomized Clinical Trial (Pilot Study)
Oocyte development begins during embryonic life and remains arrested in prophase I until meiotic resumption during ovulation. A substantial proportion of oocytes retrieved during assisted reproductive procedures remain immature at the metaphase I (MI) stage and fail to achieve the maturation required for fertilization. In women with diminished ovarian reserve, alterations in the ovarian microenvironment may impair the biochemical signaling necessary for normal oocyte development. Autologous exosomes have emerged as a potential strategy to enhance meiotic progression through the transfer of bioactive molecules. This study aimed to evaluate the in vitro efficacy of autologous exosomes in improving the maturation potential of immature oocytes in women with diminished ovarian reserve. A prospective, randomized, controlled pilot study was conducted in 32 women aged 38–46 years. A total of 111 oocytes were retrieved (52 metaphase II [MII] and 59 MI oocytes), and only MI oocytes were included in the experimental analysis. MI oocytes were cultured either in conventional medium or in medium supplemented with autologous exosomes. The exosome-supplemented group demonstrated significantly higher in vitro maturation rates compared with the conventional culture group (63.63% vs. 11.53%; p < 0.001). Fertilization rates among matured oocytes were 76.19% and 33.33% in Groups II and I, respectively. In addition, favorable embryo development outcomes were observed in the exosome-treated group. Autologous exosome supplementation may enhance in vitro maturation and fertilization outcomes in women with diminished ovarian reserve. After accounting for clustering of oocytes within patients using generalized estimating equations, exosome supplementation remained significantly associated with successful oocyte maturation (OR 15.46, 95% CI 5.16–46.39; p < 0.001).